Market Overview
The Canada bioresorbable polymers market size reached USD 178.0 Million in 2024. The market is projected to grow at a CAGR of 8.80% during the forecast period from 2025 to 2033 and is expected to reach USD 379.0 Million by 2033. Bioresorbable polymers, absorbable by the body without mechanical removal, are used extensively in medical applications including drug delivery, orthopedic fixation, and dental implants. Their physical and degradation properties, alongside expanding clinical applications, are contributing to robust market growth.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Canada Bioresorbable Polymers Market Key Takeaways
- Current Market Size in 2024: USD 178.0 Million
- CAGR (2025-2033): 8.80%
- Forecast Period: 2025-2033
- Bioresorbable polymers can be absorbed by the body, eliminating the need for mechanical removal.
- Key product segments include polylactic acid, polyglycolic acid, polycaprolactone, polysaccharides, and proteins.
- Major applications encompass drug delivery, orthopaedic fixation, dental implants, tissue staples, and sutures.
- The growing geriatric population in Canada is increasing demand due to rising cases of osteoporosis and osteoarthritis.
- Bioresorbable polymers are gaining traction in wound management and tissue engineering, enhancing product versatility.
Sample Request Link: https://www.imarcgroup.com/canada-bioresorbable-polymers-market/requestsample
Market Growth Factors
The factors influencing the growth of bioresorbable polymers in the biomedical industry, such as prostheses, sutures, orthopedic surgery, and implants, include high solubility and rapid healing, which directly improve patient care and clinical outcomes and eliminate complex surgical procedures in Canada bioresorbable polymers market.
The growing geriatric population in Canada is expected to increase the bioresorbable polymer-based medical products market. A rising number of cases of osteoporosis and osteoarthritis among geriatric patients is also expected to increase the market during the forecast period.
Canada bioresorbable polymers market growth can be attributed to the increasing use of bioresorbable polymers in wound care, as they provide an excellent barrier to bacterial penetration while enhancing oxygen permeability and promoting faster healing. The polymers may also be used as drug delivery agents, for example to deliver antibiotics or anti-cancer agents in a controlled way, increasing their demand.
Other key growth factors in the Canada market are the rising use of bioresorbable polymer powders in dermal filler applications, and the increasing demand for 3D scaffold printing for tissue engineering to create organ-like structures.
To get more information on this market, Request Sample
Market Segmentation
Breakup by Product:
- Polylactic Acid: Widely used bioresorbable polymer known for its biodegradability and biocompatibility.
- Polyglycolic Acid: Commonly applied polymer with fast degradation suitable for various medical implants.
- Polycaprolactone: Offers flexible physical properties and prolonged degradation times, ideal for specialized medical uses.
- Polysaccharides: Naturally derived polymers that are used for varied biomedical applications.
- Proteins: Bio-based polymers supporting specific biomedical functionalities.
- Others: Additional bioresorbable polymers not classified under the main categories.
Breakup by Application:
- Drug Delivery: Utilization of bioresorbable polymers as carriers for controlled and sustained drug release.
- Orthopaedic Fixation: Application in devices and implants for bone and tissue repair.
- Dental Implants: Use in dental restoration and implant technologies.
- Tissue Staples: Utilized for wound closure and surgical procedures.
- Sutures: Absorbable stitching materials aiding surgical wound healing.
- Others: Additional biomedical applications of bioresorbable polymers.
Breakup by End Use:
- Hospitals: Primary healthcare facilities using bioresorbable polymer products extensively.
- Ambulatory Surgical Centers: Outpatient care centers implementing these polymers in various procedures.
- Others: Additional healthcare settings employing bioresorbable polymers.
Regional Insights
The report specifically focuses on the Canadian market for bioresorbable polymers. The market in Canada is witnessing significant growth due to factors such as expanding geriatric demographics and increasing application in medical fields including tissue engineering, wound management, and drug delivery. The Canada bioresorbable polymers market size was USD 178.0 Million in 2024, expected to reach USD 379.0 Million by 2033 with an 8.80% CAGR during 2025-2033.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=6100&flag=C
Key Players
- Ashland
- Bezwada Biomedical LLC
- Corbion
- Evonik Industries
- Foster Corporation
- Polysciences, Inc.
- Putnam Plastics
- Zeus Industrial Products, Inc.
Customization Note
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302